PEN-VEE SUSPENSION 300MG/5ML DIN 02043300
Health Canada record
| Active ingredient(s) | PENICILLIN V BENZATHINE 300 MG |
|---|---|
| Dosage form | Suspension |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01CE10 BENZATHINE PHENOXYMETHYLPENICILLIN |
| Original market date | 31-Dec-1994 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PENICILLIN V BENZATHINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00247359 | PEN VEE SUS 180MG | WYETH LTD. | Liquid | PENICILLIN V BENZATHINE 180 MG | Cancelled Post Market |
| 02043297 | PEN-VEE SUSPENSION 180MG/5ML | WYETH-AYERST CANADA INC. | Suspension | PENICILLIN V BENZATHINE 180 MG | Cancelled Post Market |